Renal follow up of premature infants with and without perinatal indomethacin exposure
R Ojalaa, M Ala-Houhalaa, S Ahonenb, A Harmoinenc, V Turjanmaad, S Ikonena, O Tammelaa
a Department of
Paediatrics, Tampere University Hospital, PO Box 2000, FIN 33521, Tampere, Finland, b Department of Radiology,
Tampere University Hospital, c Department of Clinical Chemistry, Tampere
University Hospital, d Department
of Clinical Physiology, Tampere University Hospital
Correspondence to: Dr Ojala riitta.l.ojala{at}uta.fi
Accepted 10 August
2000
AIMS
To evaluate early childhood
renal growth, structure, and function in children born at less than 33 weeks gestation and to investigate possible independent effects of
perinatal indomethacin exposure.
METHODS
A total of 66 children born
at less than 33 weeks gestation, 31 of them with perinatal indomethacin
exposure (study group) and 35 without (control group), were examined at
2-4 years of age. Serum cystatin C and protein; plasma creatinine,
sodium, and potassium; urine protein, calcium:creatinine ratios, and
1 microglobulin; and glomerular filtration rate (GFR)
were determined. Renal sonography examinations were performed.
RESULTS
The mean serum cystatin C
concentrations were slightly higher in the control group than in the
study group. Mean values of serum protein, and plasma creatinine and
sodium did not differ between the groups, neither did median plasma
potassium concentrations and urine protein:creatinine and
calcium:creatinine ratios. None had tubular proteinuria. Abnormal GFR
(<89 ml/min/1.73 m2) was found in one case in each group
and renal structural abnormalities in five in each group. In logistic
regression analysis the duration of umbilical artery catheter (UAC) use
and furosemide treatment emerged as the significant independent risk
factors for renal structural abnormalities. Furosemide treatment and
assisted ventilation remained the risk factors associated with renal
abnormalities in general
that is, functional and/or structural
abnormal findings.
CONCLUSION
Perinatal indomethacin
does not seem to affect long term renal growth, structure, or function
in children born at less than 33 weeks gestation. Duration of UAC use,
furosemide treatment, and assisted ventilation may be correlated with
later renal structural and functional abnormalities.
|
Key messages
|
Keywords: preterm infants; indomethacin; renal; follow up
© 2001 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Cataldi, L, Leone, R, Moretti, U, De Mitri, B, Fanos, V, Ruggeri, L, Sabatino, G, Torcasio, F, Zanardo, V, Attardo, G, Riccobene, F, Martano, C, Benini, D, Cuzzolin, L
(2005). Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch. Dis. Child. Fetal Neonatal Ed.
90: F514-F519
[Abstract] [Full Text] -
Lee, J., Rajadurai, V. S., Tan, K. W., Wong, K. Y., Wong, E. H., Leong, J. Y. N.
(2003). Randomized Trial of Prolonged Low-Dose Versus Conventional-Dose Indomethacin for Treating Patent Ductus Arteriosus in Very Low Birth Weight Infants. Pediatrics
112: 345-350
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



